Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2025-12-24 @ 1:17 PM
NCT ID:
NCT02448095
Eligibility Criteria:
Inclusion Criteria:
* CML Ph+ patients in chronic phase
* 18 years old or older
* Patients have received either Dasatinib or Nilotinib and resulted resistant or not tolerant to the drugs or have developed the T3151 mutation
* Patients have started Ponatinib at least 12 months before registration
* Informed consent signed at registration
Exclusion Criteria:
* CML Ph+ patients in accelerated or blast phase with acute lymphoblastic leukemia
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02448095
Study Brief:
Protocol Section:
NCT02448095